Effects of low-intensity extracorporeal shock wave therapy on lipopolysaccharide cystitis in a rat model of interstitial cystitis/bladder pain syndrome

Int Urol Nephrol. 2024 Jan;56(1):77-86. doi: 10.1007/s11255-023-03770-3. Epub 2023 Sep 5.

Abstract

Purpose: To investigate the effect of low-intensity extracorporeal shock wave therapy (LiESWT) on lipopolysaccharide (LPS)-induced cystitis in an animal model of interstitial cystitis/bladder pain syndrome (IC/BPS).

Methods: Sprague-Dawley rats were divided into three groups: control, cystitis (LPS group, intravesical injection of LPS (1 mg) twice), and cystitis with LiESWT (LiESWT group). On the third and fourth days, LiESWT was administered (0.12 mJ/mm2, 300 shots each time) on the lower abdomen toward the bladder. On the seventh day, the rats underwent pain assessment and a metabolic cage study. Subsequently, a continuous cystometrogram (CMG) was performed under urethane anaesthesia. Immunohistochemical studies were also performed, including S-100 staining, an immunohistochemical marker of Schwann cells in the bladder.

Results: In the LPS group, the pain threshold in the lower abdomen was significantly lower than that in the control group. In the metabolic cage study, the mean voided volume in the LPS group significantly increased. The CMG also revealed a significant decrease in bladder contraction amplitude, compatible with detrusor underactivity in the LPS group. Immunohistochemical studies showed inflammatory changes in the submucosa, increased fibrosis, and decreased S-100 stain-positive areas in the muscle layer of the LPS group. In the LiESWT group, tactile allodynia and bladder function were ameliorated, and S-100 stain-positive areas were increased.

Conclusion: By restoring nerve damage, LiESWT improved lower abdominal pain sensitivity and bladder function in an LPS-induced cystitis rat model. This study suggests that LiESWT may be a new therapeutic modality for IC/BPS.

Keywords: Bladder pain syndrome; Detrusor underactivity; Interstitial cystitis; Low-intensity extracorporeal shockwave therapy; Nerve regeneration.

MeSH terms

  • Animals
  • Cystitis* / chemically induced
  • Cystitis* / complications
  • Cystitis* / therapy
  • Cystitis, Interstitial* / drug therapy
  • Cystitis, Interstitial* / therapy
  • Disease Models, Animal
  • Extracorporeal Shockwave Therapy*
  • Lipopolysaccharides / therapeutic use
  • Lipopolysaccharides / toxicity
  • Rats
  • Rats, Sprague-Dawley
  • S100 Proteins

Substances

  • Lipopolysaccharides
  • S100 Proteins